Kay NE - Search Results

1

Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia.

Browning RL, Geyer SM, Johnson AJ, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Zent CS, Bone ND, Dewald GW, Lin TS, Heerema NA, Grever MR, Kay NE, Byrd JC, Lucas DM. Browning RL, et al. Among authors: kay ne. Leuk Res. 2007 Dec;31(12):1737-40. doi: 10.1016/j.leukres.2007.05.020. Epub 2007 Jul 19. Leuk Res. 2007. PMID: 17659340 Free PMC article. Clinical Trial.

2

Chronic lymphocytic leukemia: recommendations.

Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Oken MM, Schiffer CA, Keating MJ, Boldt DH, Kempin SJ, et al. Cheson BD, et al. Among authors: kay ne. Ann Intern Med. 1989 Apr 15;110(8):664-5. doi: 10.7326/0003-4819-110-8-664. Ann Intern Med. 1989. PMID: 2930097 No abstract available.

3

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.

Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Boldt DH, Kempin SJ, et al. Cheson BD, et al. Among authors: kay ne. Am J Hematol. 1988 Nov;29(3):152-63. doi: 10.1002/ajh.2830290307. Am J Hematol. 1988. PMID: 3189311

4

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. Cheson BD, et al. Blood. 1996 Jun 15;87(12):4990-7. Blood. 1996. PMID: 8652811 Free article. No abstract available.

5

Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial.

Kay NE, Leong T, Kyle RA, Greipp P, Billadeau D, Van Ness B, Bone N, Oken MM. Kay NE, et al. Blood. 1997 Jul 1;90(1):340-5. Blood. 1997. PMID: 9207470 Free article. Clinical Trial.

6

T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93.

Kay NE, Leong T, Bone N, Kyle RA, Greipp PR, Van Ness B, Oken MM. Kay NE, et al. Br J Haematol. 1998 Mar;100(3):459-63. doi: 10.1046/j.1365-2141.1998.00609.x. Br J Haematol. 1998. PMID: 9504626 Free article. Clinical Trial.

7

Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).

Kay N, Leong T, Kyle RA, Greipp P, Van Ness B, Bone N, Oken MM. Kay N, et al. Leuk Lymphoma. 1999 Mar;33(1-2):127-33. doi: 10.3109/10428199909093733. Leuk Lymphoma. 1999. PMID: 10194129 Clinical Trial.

8

Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.

Kay NE, Han L, Bone N, Williams G. Kay NE, et al. Br J Haematol. 2001 Mar;112(3):760-7. doi: 10.1046/j.1365-2141.2001.02605.x. Br J Haematol. 2001. PMID: 11260081 Free article.

9

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Jun;25(6):485-6. doi: 10.1016/s0145-2126(01)00008-x. Leuk Res. 2001. PMID: 11337021 No abstract available.

10

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Aug;25(8):709-10. doi: 10.1016/s0145-2126(01)00002-9. Leuk Res. 2001. PMID: 11397477 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters